These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22492771)

  • 1. Severe pulmonary hypertension with therapeutic L-lysine ibuprofen in 2 preterm neonates.
    Amendolia B; Lynn M; Bhat V; Ritz SB; Aghai ZH
    Pediatrics; 2012 May; 129(5):e1360-3. PubMed ID: 22492771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in an infant treated with ibuprofen.
    Sehgal A; Kumarshingri PS
    Indian J Pediatr; 2013 Aug; 80(8):697-9. PubMed ID: 22843343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus.
    Bellini C; Campone F; Serra G
    CMAJ; 2006 Jun; 174(13):1843-4. PubMed ID: 16785458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants.
    Aranda JV; Clyman R; Cox B; Van Overmeire B; Wozniak P; Sosenko I; Carlo WA; Ward RM; Shalwitz R; Baggs G; Seth A; Darko L
    Am J Perinatol; 2009 Mar; 26(3):235-45. PubMed ID: 19067286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
    Gouyon JB; Kibleur Y
    Clin Ther; 2010 Sep; 32(10):1740-8. PubMed ID: 21194597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants.
    Richards J; Johnson A; Fox G; Campbell M
    Pediatrics; 2009 Aug; 124(2):e287-93. PubMed ID: 19651568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
    Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
    Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
    Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
    JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
    Boghossian NS; Do BT; Bell EF; Dagle JM; Brumbaugh JE; Stoll BJ; Vohr BR; Das A; Shankaran S; Sanchez PJ; Wyckoff MH; Bethany Ball M;
    Early Hum Dev; 2017 Oct; 113():10-17. PubMed ID: 28697406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.
    Dani C; Poggi C; Mosca F; Schena F; Lista G; Ramenghi L; Romagnoli C; Salvatori E; Rosignoli MT; Lipone P; Comandini A
    Trials; 2016 Apr; 17():182. PubMed ID: 27038924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.
    Dani C; Bertini G; Corsini I; Elia S; Vangi V; Pratesi S; Rubaltelli FF
    Acta Paediatr; 2008 Sep; 97(9):1176-80. PubMed ID: 18624987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study.
    Aly H; Lotfy W; Badrawi N; Ghawas M; Abdel-Meguid IE; Hammad TA
    Am J Perinatol; 2007 May; 24(5):267-70. PubMed ID: 17484080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Sekar KC; Corff KE
    J Perinatol; 2008 May; 28 Suppl 1():S60-2. PubMed ID: 18446180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conservative treatment of patent ductus arteriosus in very low birth weight infants.
    Letshwiti JB; Semberova J; Pichova K; Dempsey EM; Franklin OM; Miletin J
    Early Hum Dev; 2017 Jan; 104():45-49. PubMed ID: 28042972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.